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Abstract. Gd2O3, SiO2-Gd2O3 and SiO2-MnO2 nanoparticles wеre produced by the method of 
pulsed electron evaporation of oxide targets with condensation of the vapors in a vacuum. These 
materials are considered as probable contrast agents for magnetic resonance imaging (MRI). The 
Gd2O3 nanoparticles exhibit a rather high r1 and r2 relaxivities. These results point to the 
potential of using nanocrystals for MRI diagnosis. The mesoporous nanostructures SiO2-Gd2O3 
and SiO2-MnO2 could be considered as multimodal theranostic agents. 
1.  Introduction 
In recent years magnetic resonance imaging (MRI) has become one of the leading research methods and 
its diagnostic capabilities continue to expand. The use of contrasting agents plays a significant role in 
this process and allows the differential diagnosis of pathological neoplasms with a complex structure 
(for example, small-sized tumors and / or metastatic lesions).  
Currently, a search for new contrast agents is intensively conducted [1-5]. Many of these materials 
are classified as nanoparticles. On the one hand, interest in the use of nanoparticles in MRI imaging is 
caused by the high sorption capacity of materials due to the developed surface, so that nanoparticles can 
approach biological objects, interact and connect with them. On the other hand, the magnetic properties 
of the substance change significantly during the transition to the nanostructure, as a result of which 
nanomaterials get unusual ferro- and superparamagnetic properties. 
Currently, gadolinium-based compounds using organic chelates are widely used for MRI contrast 
[6]. This is due to the fact that the gadolinium ion Gd(III) has seven unpaired f-electrons and a symmetric 
S-state, which determines the large magnetic moment on the one hand, and the slow relaxation of the 
nuclear magnetization, which is necessary in terms of the efficiency of the paramagnetic contrast agent 
on the other hand. However, due to the known toxicity of gadolinium ions Gd(III), the search for new 
biocompatible contrast agents, including those based on metal oxide nanoparticles, is actively conducted 
[2]. Such agents include gadolinium oxide Gd2O3 nanoparticles of small sizes [7]. Experimental studies 
have shown that these nanoparticles exhibit high values of relaxivity.  
Another promising agent for use as a contrast agent in MRI is manganese oxide [8]. In recent years, 
there are works devoted to the study of the properties of nanoparticles of various manganese oxides. It 
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has been shown that the main parameters of contrast agents from manganese oxides are not inferior to 
those of contrast agents based on gadolinium oxides [9, 10]. In addition, manganese ions are involved 
in biochemical processes, which allow to consider them as biocompatible materials. 
In order to reduce aggregation in aqueous suspensions, decrease toxicity, enhance contrast properties 
and targeted delivery of nanoparticles, nanoparticles coated with various shells (organic acids, dextran, 
silicon dioxide, etc.) are actively studied [11]. The use of silicon oxide in the composition of 
nanocomplexes is particularly interesting in terms of the ability to create porous structures on its basis 
for further implementation of targeted delivery [12].  
The purpose of this work is to study the relaxation of gadolinium oxide Gd2O3 nanoparticles, 
mesoporous nanostructures SiO2-Gd2O3 and SiO2-MnO2 synthesized by gas-phase evaporation of 
ceramic targets by electron beam, as well as to assess the possibility of their use as MRI contrast agents. 
2.  Experimental 
We have used a NANOBIM-2 unit (Institute of Electrophysics, Ural Branch of the Russian Academy of 
Science) to produce Gd2O3, SiO2-Gd2O3 (10% of Gd2O3) and SiO2-MnO2 (10% of MnO2) nanoparticles. 
The unit realizes the method of pulsed electron evaporation of ceramic oxide targets with condensation 
of the vapors in a vacuum or low-pressure gas and allows us to obtain nanopowders of oxides with a 
high specific surface area up to 330 m2/g with an average size of 3-10 nm [13]. The details of 
nanomaterial synthesis correspond to papers [14-16]. 
The nanoparticles were dispersed in distilled water in the concentration range 50-500 μg/ml. The 
choice of agent concentrations is determined by the compliance with the dosages used in clinical animal 
studies [4, 5]. The sodium citrate and polyethylene glycol were used as suspension stabilizers. The 
dispersion was thoroughly mixed and treated with ultrasound for 40 min. The stability of the aqueous 
nanoparticles suspensions was assessed using a sedimentation analysis consisting in measuring the time 
dependence of the transmittance of the aqueous suspension using a PE-5400 VI spectrophotometer. 
Relaxation characteristics were measured using a NMR relaxometer (M.N. Mikheev Institute of 
Metal Physics, Ural Branch of the Russian Academy of Science). The magnitude of the magnetic field 
was 0,18 T, operating frequency – 4,3 MHz. The saturation recovery (SR) pulse sequence was used to 
measure the spin-lattice relaxation time T1, the pulse sequence Carr-Purcel-Meiboom-Gill (CPMG) was 
used to measure the spin-spin relaxation time T2.  
3.  Results and discussion 
3.1.  A stability of aqueous nanoparticle suspensions 
The stability of aqueous suspensions of gadolinium oxide Gd2O3 with stabilizers PEG 2000 in ratio of 
1:1, and sodium citrate (Na3C6H5O7) in ratios of 1:1 and 2:1 (nanoparticle : stabilizer) was studied. 
Gadolinium oxide nanoparticles Gd2O3 with PEG 2000 stabilizer rather quickly settle in a solution, 
which is probably due to the process of adhesion of fine particles of dispersed systems in larger under 
the influence of adhesion forces with the formation of coagulation structures (effect of coagulation). 
Water suspensions Gd2O3 with sodium citrate in ratio 2:1 showed the best stability. In this case the rate 
of colloid sedimentation was about 1% per hour.  
Mesoporous SiO2-Gd2O3 and SiO2-MnO2 nanostructures showed better stability in aqueous solutions 
compared to pure Gd2O3 nanoparticles. Probably, the presence of silicon oxide in the composition of the 
nanocomplex prevents the processes of adhesion of nanoparticles and their aggregration in aqueous 
solutions. Adding sodium citrate stabilizer to aqueous solutions SiO2-Gd2O3 and SiO2-MnO2 decrease 
the rate of colloid sedimentation up to 1% per hour. 
 
3.2.  Relaxivities of nanoparticle suspensions 
The investigated Gd2O3, SiO2-Gd2O3 and SiO2-MnO2 nanoparticles belong to paramagnetic particles. 
When assessing the possibility of using these compounds as contrasting agents, they should be 
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considered primarily as positive agents (affecting the intensity of the MR signal by reducing the time of 
spin-lattice relaxation T1). Such compounds create local magnetic field gradients that violate the 
homogeneity of the magnetic field in these places. 
For the sample groups studied, the times of spin-lattice relaxation T1 and spin-spin relaxation T2 
were determined, the relaxation rate (r1 and r2, units – mM-1s-1) was estimated. Relaxivity can be 
calculated by the following formula [17]: Ri=1/(C[mM]∙Ti[s]), where C is the concentration of 
nanoparticles, mM; Ti (T1 or T2) is the measured time of spin-lattice or spin-spin relaxation, s. 
Figures 1-2 show the graphs of the inverse value to the relaxation times, depending on the 
concentration of solutions in units of mM. The tangent of the slope angle of the line, which is the result 
of the linear approximation of the experimental curve, is the desired value of the relaxation rate. The 
results of r1 and r2 relaxivites estimation are shown in Table 1. 
As shown in Fig.1 the relaxivity of pure gadolinium oxide nanoparticles Gd2O3 suspensions is 
sufficiently high, which corresponds to the literature data [7, 18]. The relaxivities of SiO2-Gd2O3 and 
SiO2-MnO2 nanostructures are almost two orders of magnitude lower due to the relatively low (10%) 
concentration of paramagnetic particles in the complex. It should also be noted that the ratio of relaxation 
parameters r2/r1 is about 1, which is typical for dual contrast agents in MRI. 
 
 

















Gd2O3 2,03 2,18 
SiO2-Gd2O3 (10% of Gd2O3) 0,05 0,07 
SiO2-MnO2 (10% of MnO2) 0,04 0,06 
















































Figure 1. Relaxivities r1 (a) and r2 (b) of Gd2O3 nanoparticle suspensions 
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Figure 2. Relaxivities r1 (a) and r2 (b) of SiO2-Gd2O3 (blue curve) and SiO2-MnO2 (red curve)  nanoparticles 
4.  Conclusion 
The possibility of using gadolinium oxide Gd2O3 nanoparticles, as well as SiO2-Gd2O3 and SiO2-MnO2 
nanostructures for contrast in magnetic resonance imaging has been studied. The stability of aqueous 
nanoparticle suspensions was estimated and it was shown that the optimal conditions are realized when 
using sodium citrate stabilizer in ratio of 2:1 (nanoparticle : stabilizer). 
The relaxation characteristics of several groups of samples with various concentrations were 
measured. Relaxation parameters for the studied groups are calculated. We could conclude that the 
relaxivities r1 and r2 suspensions based on gadolinium oxide Gd2O3 nanoparticles are comparable with 
the values for the studied «analogues». The relaxivity parameters for SiO2-Gd2O3 and SiO2-MnO2 
nanoparticles are much smaller, but they have a porous structure, which allows them to be considered 
as multimodal agents for diagnostics and targeted delivery. It should be noted that the ratio of relaxation 
parameters r2/r1 for all the samples studied is close to 1, which allows them to be used for contrasting 
T1 - and T2-weighted images. 
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